Position in IOVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$789,750
+$54,900 QoQ
Shares Held
225,000
+95.7% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,231,026 | $13,921,602 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
184,937 | $10,582,095 | |
| 3 | RCKT |
Rocket Pharmaceuticals, Inc.
|
2,480,468 | $8,483,200 | |
| 4 | NKTX |
Nkarta, Inc.
|
2,373,400 | $6,716,722 | |
| 5 | NVAX |
Novavax Inc
|
577,464 | $5,439,710 | |
| 6 | PLRX |
Pliant Therapeutics, Inc.
|
1,938,747 | $2,210,171 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
|
221,286 | $1,354,270 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
25,600 | $767,488 |
All Filings in IOVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $789,750 | 225,000 | Shares | Sole | 2026-05-11 | |
| 2022-12-31 | $734,850 | 115,000 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||